Step 1: Understanding the Question:
The question asks for the specific metabolic byproducts (glycosaminoglycans or GAGs) that build up in Hurler syndrome (Mucopolysaccharidosis Type I).
Step 2: Detailed Explanation:
Overview of Hurler Syndrome: It is an autosomal recessive lysosomal storage disorder caused by the deficiency of the enzyme Alpha-L-iduronidase.
Biochemical Block: Alpha-L-iduronidase is required to break down certain GAGs. When it is missing, these substances accumulate in the lysosomes of various tissues, including the liver, spleen, heart, and brain.
Specific GAGs: The specific substrates for this enzyme are Heparan sulfate and Dermatan sulfate. Their accumulation is responsible for the systemic manifestations of the disease.
Clinical Signs: The build-up causes coarse facial features (gargoylism), hepatosplenomegaly (organ enlargement), corneal clouding, and skeletal deformities.
Comparison with Hunter Syndrome: Hunter syndrome (MPS II) also involves the accumulation of Heparan and Dermatan sulfate, but it is X-linked and notably lacks corneal clouding.
Analyzing Options: Only Option C correctly identifies the pair of GAGs specific to MPS I and MPS II. Keratan sulfate (found in other options) is associated with Morquio syndrome (MPS IV).
Step 3: Final Answer:
The deficiency of alpha-L-iduronidase in Hurler syndrome leads to the pathological accumulation of Heparan sulfate and Dermatan sulfate.